Skip to main content
Figure 3 | Trials

Figure 3

From: Intravenous transplantation of mesenchymal stem cells preconditioned with early phase stroke serum: current evidence and study protocol for a randomized trial

Figure 3

Study protocol of 'STem cell Application Researches and Trials In NeuroloGy-2’ (STARTING-2) study at each timepoint. *Indicates 1 day before mesenchymal stem cell (MSC) infusion in the MSC group vs 30 days (± 2 days) after randomization in the control group. †MSC group only. ‡Will be performed at 14 days after MSC transplantation.

Back to article page

Trials

ISSN: 1745-6215